PT-141, also known as bremelanotide, is a synthetic peptide developed as a derivative of alpha-melanocyte-stimulating hormone. Designed for research applications, it functions as an agonist at melanocortin-1 and melanocortin-4 receptors. This compound is explored in experimental settings for its potential to stimulate pathways related to sexual arousal and immune system modulation.
Supplied strictly for research purposes, PT-141 is intended for controlled laboratory investigations only.